Having sufficient data is the first step to evaluating the impact of COVID-19 and designing adequate local and national public health responses for the management and containment of this pandemic. The COVID-19 Special Release presented by PINC AI™ Applied Sciences, part of Premier, is equipped with HIPAA-compliant, de-identified patient data to support COVID-19 related research needs.

Whether your organization is interested in evaluating novel testing and treatment options, supplying health systems with life-saving medications and equipment, or in ensuring patients are able to continue to manage their chronic conditions, download this white paper for a detailed description of the attributes and capabilities of PINC AI™ Healthcare Data in this special release on COVID-19.